Results 201 to 210 of about 32,820 (258)

Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. [PDF]

Rheumatology (Oxford)
Bae SS, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, Oddis CV, Abtin F, Kim GHJ, Marder G, Venuturupalli S, Dellaripa PF, Danoff S, Doyle T, Hunninghake G, Lee JS, Falk J, Johnson C, Goldin J, Tashkin D, Charles-Schoeman C, Aggarwal R.   +21 more
europepmc   +1 more source

Treatment Response and Safety Profile of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease: A Retrospective Observational Study. [PDF]

Mediterr J Rheumatol
Gkouvi A, Boutel M, Zioga N, Pagkopoulou E, Mytilinaiou M, Rampiadou C, Margaritopoulos GA, Bogdanos DP, Dimitroulas T, Simopoulou T.   +9 more
europepmc   +1 more source

The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective Analysis [PDF]

Ria Patel, Jay Pescatore, S. Gayen
openalex   +1 more source

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis. [PDF]

Am J Respir Crit Care Med
Newton CA, Thenappan A, Liu GY, Yazbeck L, Lee CT, Pugashetti JV, Wang JM, White E, Flaherty KR, Belloli EA, Sheth JS, Mohan N, Nazemi N, Yu AR, Ghodrati S, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Khalil N, Kolb M, Morisset J, Garcia CK, Chua F, Strek ME, Khor YH, Adegunsoye A, Ryerson CJ, Molyneaux PL, Oldham JM.   +30 more
europepmc   +1 more source

Gender differences in clinical features, comorbidities and prognostic outcomes in idiopathic pulmonary fibrosis-a retrospective cohort analysis from the British Thoracic Society Interstitial Lung Disease Registry. [PDF]

BMJ Open
Sia LC, Amanda G, Bączek K, Achaiah A, Sesé L, Chaudhuri N, British Thoracic Society Interstitial Lung Disease Registry Steering Group.   +6 more
europepmc   +1 more source

Efficacy of pirfenidone in fibrotic hypersensitivity pneumonitis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Uzair A, Sohail H, Sajawal M, Ijaz Bhatti N, Waseem M, Saleem A, Ishaq A, Toor Z, Ahmad O, Giri B.   +9 more
europepmc   +1 more source

Neurocognitive Impairment in Idiopathic Pulmonary Fibrosis: A Systematic Review of Current Evidence. [PDF]

Med Sci (Basel)
Mihart D, Crisan AF, Carunta V, Trăilă D, Tudorache E, Oancea C.   +5 more
europepmc   +1 more source

Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement. [PDF]

J Intern Med
Shi J, Yu C, Ke D, Yuan X, Pang Y, Wu Y, Wang T, Stultz R, Liu X, Tian X, Li M, Wang Q, Demoruelle MK, Solomon JJ, Lood C.   +14 more
europepmc   +1 more source

Pulmonary Diffusion Capacity for Carbon Monoxide (DLCO) in Indonesian Patients with End-stage Renal Disease.

, 2017
Taruli Loura Batubara, Faisal Yunus, Ratnawati Ratnawati, Yassir Yassir, Fariz Nurwidya   +4 more
openalex   +1 more source

Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis. [PDF]

BMJ Open Respir Res
Kolb M, Corte TJ, Feldman J, Nathan SD, Reisner C, Nair D, Woodhead F, Lazarus H, Conoscenti C.   +8 more
europepmc   +1 more source